Influence of argatroban on cerebral blood flow ,levels of CXCL16 and hsCRP in patients with acute cerebral infarction
10.3969/j.issn.1008-0074.2018.03.21
- VernacularTitle:阿加曲班对急性脑梗死患者脑血流及CXCL16、hsCRP水平的影响
- Author:
Bo DU
1
;
Yan-Bo CHENG
;
Hai-Liang LI
;
Long YANG
Author Information
1. 江苏省徐州医科大学附属医院神经内科
- Keywords:
Brain infarction;
C-reactive protein;
Argatroban
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2018;27(3):318-322
- CountryChina
- Language:Chinese
-
Abstract:
Objective :To explore influence of argatroban on cerebral blood flow ,levels of CXC chemokine ligand 16 (CX-CL16) and high sensitive C reactive protein (hsCRP) in patients with acute cerebral infarction (ACI).Methods :A total of 100 ACI patients were selected ,randomly and equally divided into routine treatment group and argatroban group (received argatroban based on routine treatment ) ,both groups were treated for 10d.Score of United States national institutes of health stroke score (NIHSS) ,cerebral blood flow and levels of CXCL16 and hsCRP were compared between two groups be-fore and after treatment .Results :Compared with before treatment ,after treatment ,there were significant reductions in NIHSS score ,levels of endothelin (ET)-1 ,CXCL16 and hsCRP ,and significant rise in mean blood flow velocities of mid-dle cerebral artery (MCA) and anterior cerebral artery (ACA) and nitric oxide (NO) level in two groups (P＝0.001 all) ;compared with routine treatment group after treatment ,there were significant reductions in NIHSS [ (9.78 ± 3.59) scores vs.(7.02 ± 3.67) scores] ,levels of ET-1 [(75.75 ± 10.67) pg/ml vs.(62.56 ± 9.45) pg/ml] ,CXCL16 [(2.01 ± 0.84) ng/ml vs.(1.67 ± 0.75) ng/ml] and hsCRP [(4.42 ± 1.66) mg/L vs.(3.89 ± 1.37) mg/L] ,and significant rise in mean blood flow velocities of MCA [ (48.87 ± 5.23) cm/s vs.(55.35 ± 6.35) cm/s] and ACA [ (41.25 ± 4.89) cm/s vs. (47.88 ± 5.47) cm/s] and NO level [ (55.77 ± 6.36) μmol/L vs.(65.76 ± 6.86) μmol/L] in argatroban group , P＜0.05 or ＜0.01.There was no significant difference in incidence rate of hemorrhage events between two groups (P＝0.315). Conclusion : Argatroban based on routine treatment can more effectively improve cerebral blood flow and vascular endothe-lial function ,reduce levels of CXCL 16 and hsCRP ,and improve clinical therapeutic effect .
